{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:59:42Z","timestamp":1773680382818,"version":"3.50.1"},"reference-count":13,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T00:00:00Z","timestamp":1124409600000},"content-version":"vor","delay-in-days":2787,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[1998,1]]},"abstract":"<jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> To investigate the effect of 17\u03b2\u2010oestradiol ophthalmic drops in comparison with a traditional<\/jats:p><jats:p><jats:bold>Design\n\t\t\t\t\t<\/jats:bold> Randomised prospective trial.<\/jats:p><jats:p><jats:bold>Setting\n\t\t\t\t\t<\/jats:bold> Menopause clinic.<\/jats:p><jats:p><jats:bold>Participants\n\t\t\t\t\t<\/jats:bold> Eighty\u2010four postmenopausal women suffering from keratoconjunctivitis sicca and necessitating a hormone replacement therapy (HRT) for general climacteric symptoms.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> The women were randomised into two groups and were given 17\u03b2\u2010oestradiol eye drops (<jats:styled-content>n=42<\/jats:styled-content>, group 1) or a tear substitute (<jats:styled-content>n=42<\/jats:styled-content>, group 2). Both groups received a systemic HRT.<\/jats:p><jats:p><jats:bold>Main outcome measures\n\t\t\t\t\t<\/jats:bold> A Schirmer's test was performed immediately before the beginning of therapy and after four months. In addition, eye symptoms were assessed using a visual analogue scale.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> A comparison of visual analogue scores at four months in the women who received 17\u03b2\u2010oestradiol eye drops <jats:italic>versus<\/jats:italic> those who received a tear substitute demonstrated a statistically significant difference in all observed ocular symptoms (P&lt;0.0001) The Schirmer's test revealed a significant difference of results before and after treatment in the oestradiol group (P&lt;0.0001) while in group 2 no significant difference was found.<\/jats:p><jats:p><jats:bold>Conclusions\n\t\t\t\t\t<\/jats:bold> Our study demonstrates that topical oestrogen is successful in treating keratoconjunctivitis sicca while it seems that the blood\u2010eye barrier prevents systemic oestrogens from acting on the conjunctivae.<\/jats:p>","DOI":"10.1111\/j.1471-0528.1998.tb09358.x","type":"journal-article","created":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T09:07:49Z","timestamp":1124442469000},"page":"100-102","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Treatment of menopausal keratoconjunctivitis sicca with topical oestradiol"],"prefix":"10.1111","volume":"105","author":[{"given":"Michael O.","family":"Sator","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmar A.","family":"Joura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Golaszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Frigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Metka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Hommer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes C.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,19]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(91)90141-C"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(90)32588-5"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(89)32831-4"},{"key":"e_1_2_5_5_2","first-page":"5334","article-title":"Treatment of the dry eye with vitamin A acid\u2010 an impression cytology controlled study","volume":"86","author":"Schilling H","year":"1989","journal-title":"Fortschr Ophthalmol"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000309798"},{"key":"e_1_2_5_7_2","first-page":"1381","article-title":"Stimulation of tear secretion by topical agents that increase cyclic nucleotide levels","volume":"3","author":"Gilbart JP","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1994.01090240120036"},{"key":"e_1_2_5_9_2","first-page":"226","article-title":"Tamoxifen inhibition of ocular melanoma cell attachment to matrix proteins","volume":"7","author":"Mac Neil S","year":"1994","journal-title":"Pigment Cell Res"},{"key":"e_1_2_5_10_2","first-page":"3","article-title":"(Significance of subjective sensitivity in evaluation of keratoconjunctivitis sicca.) Die Bedeutung der subjektiven Empfmdlichkeit in der Beurteilung der Keratoconjunctivitis sicca","volume":"92","author":"Stolze HH","year":"1995","journal-title":"Ophthalmolosge"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(95)30971-2"},{"key":"e_1_2_5_12_2","first-page":"1765","article-title":"Identification of an extensive system of nitric oxide\u2010producing cells in the ciliary muscle and outflow pathway of the human eye","volume":"36","author":"Nathanson JA","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_13_2","first-page":"1188","article-title":"Characterization of ciliary muscle relaxation induced by various agents in cats","volume":"36","author":"Yasumasa G","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_14_2","first-page":"289","article-title":"Are sex hormones associated with age\u2010related maculopathy in women? The beaver dam eye study","volume":"92","author":"Klein BE","year":"1994","journal-title":"Trans Am Ophthalmol Soc"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.1998.tb09358.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.1998.tb09358.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T07:11:28Z","timestamp":1698477088000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.1998.tb09358.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["10.1111\/j.1471-0528.1998.tb09358.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.1998.tb09358.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]},"assertion":[{"value":"2005-08-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}